Paragon Capital Management LTD Pfizer Inc Transaction History

Paragon Capital Management LTD

$518 Million
Q2 2025

A detailed history of Paragon Capital Management LTD transactions in Pfizer Inc stock. As of the latest transaction made, Paragon Capital Management LTD holds 24,958 shares of PFE stock, worth $615,214. This represents 0.12% of its overall portfolio holdings.

Number of Shares

24,958

Previous 17,619 41.65%

Holding current value

$615,214

Previous $446,000 35.43%

% of portfolio

0.12%

Previous 0.1%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 16, 2025	BUY	$21.59 - $24.84 $158,449 - $182,300	7,339 Added 41.65%	24,958 $604,000
Q4 2024 Jan 14, 2025	SELL	$24.8 - $30.19 $8,184 - $9,962	-330 Reduced 1.84%	17,619 $467,000
Q2 2024 Jul 12, 2024	SELL	$25.26 - $29.6 $39,506 - $46,294	-1,564 Reduced 8.02%	17,949 $502,000
Q1 2024 Apr 11, 2024	BUY	$25.89 - $29.73 $13,954 - $16,024	539 Added 2.84%	19,513 $541,000
Q4 2023 Jan 12, 2024	BUY	$26.13 - $33.94 $26,130 - $33,940	1,000 Added 5.56%	18,974 $546,000
Q2 2023 Jul 11, 2023	SELL	$36.12 - $41.79 $63,209 - $73,132	-1,750 Reduced 8.87%	17,974 $659,000
Q3 2022 Oct 14, 2022	SELL	$43.76 - $53.42 $124,978 - $152,567	-2,856 Reduced 12.65%	19,724 $863,000
Q2 2022 Jul 18, 2022	SELL	$46.53 - $55.17 $245,538 - $291,132	-5,277 Reduced 18.94%	22,580 $1.18 Million
Q1 2022 Apr 19, 2022	BUY	$45.75 - $56.69 $8,052 - $9,977	176 Added 0.64%	27,857 $1.44 Million
Q4 2021 Jan 27, 2022	SELL	$41.32 - $61.25 $31,485 - $46,672	-762 Reduced 2.68%	27,681 $1.64 Million
Q3 2021 Oct 19, 2021	SELL	$39.25 - $50.42 $70,846 - $91,008	-1,805 Reduced 5.97%	28,443 $1.22 Million
Q2 2021 Jul 29, 2021	BUY	$35.91 - $40.68 $172,439 - $195,345	4,802 Added 18.87%	30,248 $1.19 Million
Q1 2021 Apr 21, 2021	SELL	$33.49 - $37.77 $38,546 - $43,473	-1,151 Reduced 4.33%	25,446 $922,000
Q3 2020 Oct 22, 2020	BUY	$31.75 - $37.25 $844,454 - $990,738	26,597 New	26,597 $976,000
Q1 2020 Apr 29, 2020	SELL	$27.03 - $38.62 $824,171 - $1.18 Million	-30,491 Closed	0 $0
Q3 2019 Oct 18, 2019	SELL	$32.49 - $42.13 $47,305 - $61,341	-1,456 Reduced 4.56%	30,491 $1.1 Million
Q2 2019 Jul 23, 2019	SELL	$36.98 - $41.52 $49,922 - $56,052	-1,350 Reduced 4.05%	31,947 $1.38 Million
Q4 2018 Jan 29, 2019	SELL	$38.47 - $43.86 $15,157 - $17,280	-394 Reduced 1.17%	33,297 $1.45 Million
Q3 2018 Nov 05, 2018	BUY	$34.47 - $41.81 $8,824 - $10,703	256 Added 0.77%	33,691 $1.49 Million
Q2 2018 Aug 21, 2018	SELL	$32.98 - $35.16 $13,093 - $13,958	-397 Reduced 1.17%	33,435 $1.21 Million
Q1 2018 Apr 24, 2018	BUY	$31.91 - $37.02 $1.08 Million - $1.25 Million	33,832 New	33,832 $1.2 Million
Q4 2017 Jan 29, 2018	SELL	$33.26 - $35.29 $1.46 Million - $1.55 Million	-43,877 Closed	0 $0
Q3 2017 Oct 26, 2017	BUY	$31.0 - $34.15 $1.36 Million - $1.5 Million	43,877	43,877 $1.57 Million

Others Institutions Holding PFE

# of Institutions

3,286

Shares Held

3.66B

Call Options Held

95.8M

Put Options Held

121M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $138B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Paragon Capital Management LTD with notifications on news.

Account

Paragon Capital Management LTD Pfizer Inc Transaction History